Inflammatory Bowel Disease

Cross-source consensus on Inflammatory Bowel Disease from 3 sources and 15 claims.

3 sources · 15 claims

How it works

Risks & contraindications

Background

Evidence quality

Other

Highlighted claims

Inflammatory bowel disease encompasses ulcerative colitis and Crohn's disease as its main subtypes. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
Patients with primary sclerosing cholangitis were excluded from the study because PSC-IBD is considered a distinct IBD phenotype with unique clinical features. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
IBD is a chronic autoimmune disease of the gastrointestinal tract that disrupts digestion and nutrient absorption. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
Common IBD symptoms and complications include bloody diarrhoea, abdominal pain, weight loss, malnutrition, bowel strictures, fistulas, arthritis, and cancers. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
IBD treatment aims to suppress immune-mediated inflammation, with corticosteroids used for flares and maintenance therapy including immunomodulators or advanced therapies. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
South Asian Canadians have a 47% higher incidence of ulcerative colitis compared to white Canadians. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
Inflammatory bowel disease is a chronic inflammatory condition with growing incidence in newly industrialised countries including China, placing a substantial burden on healthcare resources. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
Despite advances in biologic and small-molecule therapies, a considerable proportion of IBD patients experience treatment response loss or adverse effects, driving interest in lifestyle-based interventions. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
IBD patients in both Western and Asian countries consistently demonstrate low physical activity levels. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial
A cross-sectional study in East China found that the majority of IBD patients engage in minimal to no moderate-to-vigorous physical activity even during remission, with 50.9% showing low activity and 53.2% scoring zero activity. — Telemedicine-based individualised aerobic exercise training in Chinese adults with inactive or mildly active inflammatory bowel disease: study protocol for a single-centre, semi-crossover randomised controlled trial